Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2006 by Scripps Health.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Scripps Health
ClinicalTrials.gov Identifier:
NCT00286416
First received: February 1, 2006
Last updated: November 6, 2006
Last verified: January 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2008
  Estimated Primary Completion Date: No date given